Lung ultrasound in acute and chronic heart failure: a clinical consensus statement of the European Association of Cardiovascular Imaging (EACVI)

TY - JOUR

T1 - Lung ultrasound in acute and chronic heart failure

T2 - a clinical consensus statement of the European Association of Cardiovascular Imaging (EACVI)

AU - Gargani, Luna

AU - Girerd, Nicolas

AU - Platz, Elke

AU - Pellicori, Pierpaolo

AU - Stankovic, Ivan

AU - Palazzuoli, Alberto

AU - Pivetta, Emanuele

AU - Miglioranza, Marcelo Haertel

AU - Soliman-Aboumarie, Hatem

AU - Agricola, Eustachio

AU - Volpicelli, Giovanni

AU - Price, Susanna

AU - Donal, Erwan

AU - Cosyns, Bernard

AU - Neskovic, Aleksandar N

N1 - Funding Information: Conflict of interest: Dr. Gargani: no conflict of interest related to this paper. Outside of this paper, Dr. Gargani has received consultancy honoraria from Philips Helathcare, GE Healthcare, Caption Health, EchoNous. Dr. Girerd: no conflict of interest related to this paper. Outside of this paper, Dr. Girerd has received consultancy honoraria from Astra Zeneca, Bayer, Boehringer-Ingelheim, Novartis, Lilly, Vifor International. Dr. Platz: no conflict of interest related to this paper. Outside of this paper, Dr. Platz’ employer has received support from Novartis for consulting work, and she has consulted for scPharmaceuticals. She has received research support from the NIH (R01HL148439), the American Heart Association and AstraZeneca. Dr. Pellicori: no conflict of interest related to this paper. Outside of this paper, Dr. Pellicori has received consultancy honoraria and/or sponsorship support from Boehringer Ingelheim, Pharmacosmos, Novartis, Vifor, AstraZeneca and Caption Health, and researchsupport from Bristol Myers Squibb. Dr. Stankovic: no conflict of interest related to this paper. Outside of this paper, Dr. Stankovic has received consultancy honoraria from Servier, Boehringer-Ingelheim, Pfizer, Astra Zeneca, Novartis, Merck Sharp & Dohme. Dr. Palazzuoli: no conflict of interest to declare. Dr. Pivetta: no conflict of interest related to this paper. Outside of this paper, Dr. Pivetta has received research support from Butterfly inc. Dr. Miglioranza: no conflict of interest related to this paper. Outside of this paper, Dr. Miglioranza has received consultancy honoraria from Philips, GE Healthcare, Abbott. Dr. Aboumarie: no conflict of interest to declare. Dr. Agricola: no conflict of interest related to this paper. Outside of this paper, Dr. Agricola has received consultancy honoraria from Philips, Edwards Lifesciences. Dr. Volpicelli: no conflict of interest to declare. Dr. Price: no conflict of interest to declare. Dr. Donal: no conflict of interest related to this paper. Outside of this paper, Dr. Donal has received research funding from Abbott. Dr. Cosyns: no conflict of interest related to this paper. Outside of this paper, Dr. Cosyns has received research funding from Abbott. Dr. Neskovic: no conflict of interest related to this paper. Outside of this paper, Dr. Neskovic has received consultancy honoraria from Bayer, AstraZeneca, Pfizer, Boehringer Ingelheim, Servier and Novartis.

PY - 2023/11/23

Y1 - 2023/11/23

KW - Humans

KW - Ultrasonography/methods

KW - Heart Failure/diagnostic imaging

KW - Lung/diagnostic imaging

UR - http://www.scopus.com/inward/record.url?scp=85174976305&partnerID=8YFLogxK

U2 - 10.1093/ehjci/jead169

DO - 10.1093/ehjci/jead169

M3 - Article

C2 - 37450604

SN - 2047-2404

VL - 24

SP - 1569

EP - 1582

JO - European heart journal. Cardiovascular Imaging

JF - European heart journal. Cardiovascular Imaging

IS - 12

ER -